Pharmacokinetics of green tea catechins in extract and sustained-release preparations

Journal of Dietary Supplements

Volumn 5, Issue 3, 2008, Pages 248-263

  Janle, Elsa M ^a   Morré, Dorothy M ^a   Morré, D James ^a   Zhou, Qin ^b   Zhu, Yongxin ^c  

^a PURDUE UNIVERSITY   (United States)

^b Ventura College   (United States)

^c JNJ   (United States)

Author keywords

Green tea pharmacokinetics; Sustained release

Indexed keywords

CATECHIN; PLANT EXTRACT;

ANIMAL; APOPTOSIS; ARTICLE; CAMELLIA SINENSIS; CHEMISTRY; DELAYED RELEASE FORMULATION; GREEN TEA PHARMACOKINETICS; MALE; NEOPLASM; PHYTOTHERAPY; RAT; SPRAGUE DAWLEY RAT; SUSTAINED DRUG RELEASE;

GREEN TEA PHARMACOKINETICS; SUSTAINED RELEASE;

ANIMALS; APOPTOSIS; CAMELLIA SINENSIS; CATECHIN; DELAYED-ACTION PREPARATIONS; MALE; NEOPLASMS; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 58149168556     PISSN: 19390211     EISSN: None     Source Type: Journal    
DOI: 10.1080/19390210802414279     Document Type: Article

References (28)

1. Ahmad N, Feyes DK, Nieminen AL, Agarwal R, Mukhtar H. Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Instit. 1997;89:1881-86.
2. Bushman JL. Green tea and cancer in humans: a review of the literature. Nutr Cancer. 1998;31:151-59.
3. Chen ZP, Schell JB, Ho CT, Chen KY. Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts. Cancer Lett. 1998; 129:173-79.
4. Conney AH, Lu Y-P, Lou Y-R, Xie J-G, Huang M-T. Inhibition effect of green and black tea on tumor growth. Pro Soc Exper Biol Med. 1999;220:229-33.
5. Cooper R, Morré DJ, Morré DM. Medicinal benefits of green tea: Part II. Review of anticancer properties. J Altern Complement Med. 2005; 11:639-52.
6. Dreosti IE. Bioactive ingredients: antioxidants and polyphenols in tea. Nutr Rev.1996;54:S51-S58.
7. Fujiki H, Suganuma M, Okabe S, Sueoka N, Imai K, Nakachi S, et al. Mechanistic findings of green tea as cancer preventive for humans. Proc Soc Exp Biol Med. 1999; 220:225-28.
8. Green RJ, Murphy AS, Schulz B, Watkins BA, Ferruzzi MG. Common tea formulations modulate in vitro digestive recovery of green tea catechins. Molecular Nutrition and Food Research. 2007; 51:1152-62.
9. Guo Y, McLaughlin JK, Blot WJ, Ji BT, Dai Q, Fraumeni JR, Jr. Reduced risk of esophageal cancer associated with green tea consumption. J Nat Can Inst. 1994;86:855-58.
10. Gupta S, Hastak K, Ahmad N, Lewin JS, Mukhtar H. Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc Nat Acad Sci USA. 2001;98:10350-55.
11. Imai K, Litt O, Suga K, Nakachi K. Cancer preventative effects of drinking green tea among a Japanese population. Prevent Med. 1997;26:769-75.
12. Janle EM, Portocarrero C, Zhu Y, Zhou Q. Effect of long-term oral administration of green tea extract on weight gain and glucose tolerance in zucker diabetic (ZDF) rats. J Herbal Pharmacother. 2005;5:55-64.
13. Ji B-T, Chow WH, Hsing AW, McLaughlin JK, Dai Q, Guo YT, et al. Green tea consumption and the risk of pancreatic and colorectal cancers. Int J Cancer. 1997;70:255-58.
14. Ji B-T, Chow WH, Yang G, McLaughlin JK, Gao RN, Zheng W, et al. The influence of cigarette smoking, alcohol and green tea consumption on the risk of carcinoma of the cardia and distal stomach in Shanghai, China. Cancer. 1996;77:2449-57.
15. Katdare M, Osborn MP, Telang NT. Inhibition of aberrant proliferation and induction of apoptosis in pre-neoplastic human mammary epithelial cells by natural phytochemicals. Oncol Repts. 1998;5:311-15.
16. Kono S, Ikada M, Tokudome S, Kuratsune M. A case control study of gastric cancer and diet in Northern Kyishu, Japan. Jpn J Cancer Res. 1988;79:1067-74.
17. Liao S, Kao Y-H, Hiipakka RA. Green tea:biochemical and biological basis for health benefits vitamins and hormones. Vitam Horm. 2001; 62:1-94.
18. Liao S, Umekita Y, Guo J, Kokontis JM, Hiipakka RA. Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gállate. Cancer Lett. 1995;96:239-43.
19. Morre DJ, Bridge A, Wu LY, Morre DM. Preferential inhibition by (-)-epigallocatechin-3-gallate of the cell surface NADH oxidase and growth of transformed cells in culture. Biochem Pharmacol. 2000;60:937-46.
20. Morré D, Morré DJ, Cooper R, Chang MN. Tea catechins in sustained release formulations as cancer-specific proliferation inhibitors. United States Patent Number 6,410,052, Issued June 25, 2002.
21. Morre DJ, Morre DM, Sun H, Cooper R, Chang J, Janle EM. Tea catechin synergies in inhibition of cancer cell proliferation and of a cancer specific cell surface oxidase (ECTO-NOX). Pharmacol Toxicol. 2003;92:234-41.
22. Nakagawa KMT. Absorption and distribution of tea catechin, (-)-epigallocatechin-3-gallate, in the rat. J Nutr Sci Vitaminol. 1997;43:679-84.
23. Nakagawa K, Okuda S, Miyazawa T. Dose-dependent incorporation of tea catechins, (-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma. Biosci Biotechnol Biochem. 1997;61:1981-85.
24. Unno T, Takeo T. Absorption, distribution, elimination of tea polyphenols in rats. Absorption of (-)-epigallocatechin gallate into the circulation system of rats. Biosci Biotechnol Biochem. 1995;59:1558-59.
25. Warden BA, Smith LS, Beecher GR, Balentine DA, Clevidence BA. Catechins are bioavailable in men and women drinking black tea throughout the day. J Nutr. 2001;131:1731-37.
26. Yang CS. Inhibition of carcinogenesis by tea. Nat Clin Prac Cardiovasc Med. 1997;389:134-35.
27. Yu GP, Hsich CC, Wang LY, Yu SZ, Li XL, Jin TH. Green tea consumption and risk of stomach cancer: a population-based case-control study in Shanghai, China. Cancer Causes Control. 1995;6:532-38.
28. Zhu M, Chen Y, Li RC. Oral absorption and bioavailability of tea catechins. Planta Med. 2000;66:444-47.